Squarepoint’s CytRx Corp CYTR Stock Holding History

Squarepoint’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,839	Closed	-$33K	–	2064
2017 Q2	$33K	Buy	+8,839	New	+$30.2K	﹤0.01%	1472

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Squarepoint's CYTR Position: Q3 2017 in Review

Squarepoint sold out of CytRx Corp (CYTR) in Q3 2017, closing a stake of 8,839 shares — an estimated $33K sold.

Squarepoint first reported a position in CYTR in Q2 2017 and held it in 1 quarter. The position peaked at $33K in Q2 2017. 47 funds tracked by Wall St. Rank hold CYTR as of Q3 2017.

Squarepoint reported no remaining CytRx Corp position as of Q3 2017 after selling out during the quarter.
Squarepoint sold 8,839 CytRx Corp shares in Q3 2017, an estimated $33K.
Squarepoint first reported a position in CytRx Corp in Q2 2017 and held it in 1 quarter.
Squarepoint's CytRx Corp position peaked at $33K in Q2 2017.
47 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2017.

Based on Squarepoint's 13F filing for Q3 2017, filed 14 Nov 2017.